EMD Serono brings back "Birds & Bees" infertility effort

Share this article:
EMD Serono refreshed its "Birds & Bees" fertility issues awareness campaign with a Facebook page and a music video.

The light-hearted campaign, by agency WCG, features a costumed thirtysomething suburban everycouple -- she a bird, he a bee -- struggling to concieve. Where last year's executions largely played it straight, duds aside, the new work takes a more comical bent. The music video, similar to Toyota's "Swagger Wagon" spot, which was similarly aimed at new and wannabe moms, has Karen and Neil rapping and singing through an R&B number entitled "The Early Bird Gets the Sperm (raps Kate Miccuci-esque Karen: "I do prenatal yoga / And I follow every detox / I heard high heels make you infertile / So I only wear my Reeboks / I drink these nasty smoothies / And I do the acupuncture / My cervical mucus is as thick as peanut butter")."

The idea, said a company spokesperson, is to get around the stigma around fertility issues and "break the ice" with couples who are trying to concieve, encouraging them to talk to a reproductive endocrinologist about their options. The company offers a doctor finder through its patient support website, FertilityLifeLines.com.

EMD Serono's fertility products include Gonal-F, Ovidrel, Luveris and Cetrotide, all hormone treatments. The company estimates that 7.3 million Americans are wrestling with fertility issues.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...